Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc.

新泽西州 - Citius Oncology, Inc. (NASDAQ: CTOR )周五宣布，该公司已实施一个人工智能平台，以增强其商业运营，为预期推出的皮肤T细胞淋巴瘤 (CTCL)治疗药物LYMPHIR做准备。母公司Citius Pharmaceuticals (NASDAQ: CTXR )目前交易价格为$1.23，根据 InvestingPro ...

Markets regulator Securities and Exchange Board of India (SEBI) has imposed a penalty of Rs2 lakh on SMC Global Securities ...

Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling breakout potential in biotech & pharma.

DelveInsight's HDAC Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

DelveInsight’s report, “Behcet’s Disease Market Insights, Epidemiology, and Market Forecast – 2034” provides a comprehensive ...

爸爸带娃丝滑漂移，动作简直太丝滑，宝宝：你觉得我想玩吗 ...